2026
conference-abstract
OpenAlex
Amirah Etchegaray, Naeman Goetz, Satomi Okano, Günter Härtel et autres
Abstract Background The clinical heterogeneity of acute Ulcerative Colitis (UC) poses a notable challenge to effective risk stratification and timely intervention. Existing severity indices derived in the 20th century may be obfuscated by the effects of novel therapeutics and fail to capture …
au
(code pays fourni par la source)
2026
conference-abstract
OpenAlex
George Tambakis, Satomi Okano, Günter Härtel, Raman Kumar et autres
Abstract Background Inflammatory bowel disease (IBD), including ulcerative colitis (UC), Crohn’s disease (CD) represents a spectrum of chronic inflammatory conditions affecting the gastrointestinal tract. Whilst some patients experience a benign disease course, others develop complicated IBD characterised by frequent hospitalisations and surgery. …
au
(code pays fourni par la source)
2026
conference-abstract
OpenAlex
Naeman Goetz, Satomi Okano, Günter Härtel, George Tambakis et autres
Abstract Background Baseline C-reactive protein (CRP) is a well-established biomarker for assessing corticosteroid response in acute severe ulcerative colitis (ASUC). With 56% of Australian inflammatory bowel disease (IBD) patients classified as overweight or obese, understanding how excess adiposity influences treatment response is …
au
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Satomi Okano, Yoshio Makita, Yuki Ueda, Akie Miyamoto et autres
Sodium/potassium (Na+/K+) ATPase is a heteromeric protein complex responsible for maintaining the Na+/K+ electrochemical gradient across the neuronal plasma membrane. The α3 isoform of the Na+/K+ ATPase, encoded by ATP1A3, acts as a rescue pump and is predominantly present in the neurons …
jp
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Emily Lim, Maxter Thai, Yoon‐Kyo An, Peter J Hendy et autres
Background: Endoscopic balloon dilatation (EBD) is an alternative therapy to avoid or delay surgery in stricturing Crohn’s disease (CD); however, certain factors determining outcomes remain poorly defined, and conflicting evidence exists in current studies. In one of the largest cohorts to date, …
au, gb, nz
(code pays fourni par la source)
2023
article
OpenAlex
Satomi Okano, Araki Akiko, Kayano Kimura, Ikue Fukuda et autres
jp
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Satomi Okano, Yoshio Makita, Akie Miyamoto, Genya Taketazu et autres
The X-linked human glutamate receptor subunit 3 (GRIA3) gene (MIM *305915, Xq25) encodes ionotropic α amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)-type glutamate receptor subunit 3, which mediates postsynaptic neurotransmission. Variants in this gene can cause a variety of neurological disorders, primarily reported in male patients. …
jp
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Satomi Okano, Yoshio Makita, Kayano Kimura, Ikue Fukuda et autres
BACKGROUND: Wisconsin syndrome is a congenital anomaly caused by a 3q interstitial deletion. It is associated with characteristic facies and developmental delays. Only 33 cases with a deletion estimated to be in the associated region 3q25 have been reported. CASE REPORT: We …
jp
(code pays fourni par la source)
2020
article
OpenAlex
Satomi Okano, Akie Miyamoto, Yoshio Makita, Genya Taketazu et autres
jp
(code pays fourni par la source)
2020
article
OpenAlex
Hajime Tanaka, Satomi Okano, Kimura Kayano, Ikue Fukuda et autres
2019
article
OpenAlex
Satomi Okano, Sorachi Shimada, Ryosuke Tanaka, Akie Okayama et autres
jp, us
(code pays fourni par la source)
Accès ouvert
2019
article
OpenAlex
Satomi Okano, Yoshio Makita, Akihiro Katada, Yasuaki Harabuchi et autres
Abstract Usher syndrome type I (USH1) is characterized by congenital, bilateral, profound sensorineural hearing loss, vestibular areflexia, and adolescent-onset retinitis pigmentosa. Here, we report a 12-year-old female patient with typical USH1. Targeted panel sequencing revealed compound heterozygous variants of the Cadherin 23 …
jp
(code pays fourni par la source)